Guidelines for application of continuous subcutaneous insulin infusion (insulin pump) therapy in the perioperative period

Mary E. Boyle, Karen M. Seifert, Karen A. Beer, Heidi A. Apsey, Adrienne A. Nassar, Stephanie D. Littman, Janice M. Magallanez, Richard T. Schlinkert, Joshua D. Stearns, Michael J. Hovan, Curtiss B. Cook

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Case reports indicate that diabetes patients receiving outpatient insulin pump therapy have been allowed to continue treatment during surgical procedures. Although allowed during surgery, there is actually little information in the medical literature on how to manage patients receiving insulin pump therapy during a planned surgical procedure. A multidisciplinary work group reviewed current information regarding the use of insulin pumps in the perioperative period. Although the work group identified safety issues specific to surgical scenarios, it believed that with the use of standardized guidelines and a checklist, continuation of insulin pump therapy during the perioperative period is feasible. A sample set of protocols have been developed and are summarized. A policy outlining clear procedures should be established at the institutional level to guide physicians and other staf if the devices are to be employed during the perioperative period. Additional clinical experience with the technology in surgical scenarios is needed, and consensus should be developed for insulin pump use in the perioperative phases of care.

Original languageEnglish (US)
Pages (from-to)184-190
Number of pages7
JournalJournal of diabetes science and technology
Volume6
Issue number1
DOIs
StatePublished - 2012

Fingerprint

Subcutaneous Infusions
Infusion Pumps
Perioperative Period
Insulin
Pumps
Guidelines
Perioperative Care
Therapeutics
Medical problems
Checklist
Surgery
Outpatients
Technology
Physicians
Safety
Equipment and Supplies

Keywords

  • Diabetes mellitus
  • Insulin pump
  • Perioperative care

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Bioengineering
  • Biomedical Engineering

Cite this

Guidelines for application of continuous subcutaneous insulin infusion (insulin pump) therapy in the perioperative period. / Boyle, Mary E.; Seifert, Karen M.; Beer, Karen A.; Apsey, Heidi A.; Nassar, Adrienne A.; Littman, Stephanie D.; Magallanez, Janice M.; Schlinkert, Richard T.; Stearns, Joshua D.; Hovan, Michael J.; Cook, Curtiss B.

In: Journal of diabetes science and technology, Vol. 6, No. 1, 2012, p. 184-190.

Research output: Contribution to journalArticle

Boyle, ME, Seifert, KM, Beer, KA, Apsey, HA, Nassar, AA, Littman, SD, Magallanez, JM, Schlinkert, RT, Stearns, JD, Hovan, MJ & Cook, CB 2012, 'Guidelines for application of continuous subcutaneous insulin infusion (insulin pump) therapy in the perioperative period', Journal of diabetes science and technology, vol. 6, no. 1, pp. 184-190. https://doi.org/10.1177/193229681200600123
Boyle, Mary E. ; Seifert, Karen M. ; Beer, Karen A. ; Apsey, Heidi A. ; Nassar, Adrienne A. ; Littman, Stephanie D. ; Magallanez, Janice M. ; Schlinkert, Richard T. ; Stearns, Joshua D. ; Hovan, Michael J. ; Cook, Curtiss B. / Guidelines for application of continuous subcutaneous insulin infusion (insulin pump) therapy in the perioperative period. In: Journal of diabetes science and technology. 2012 ; Vol. 6, No. 1. pp. 184-190.
@article{5fabb553275a49e8b5dcaa2c2ab3062c,
title = "Guidelines for application of continuous subcutaneous insulin infusion (insulin pump) therapy in the perioperative period",
abstract = "Case reports indicate that diabetes patients receiving outpatient insulin pump therapy have been allowed to continue treatment during surgical procedures. Although allowed during surgery, there is actually little information in the medical literature on how to manage patients receiving insulin pump therapy during a planned surgical procedure. A multidisciplinary work group reviewed current information regarding the use of insulin pumps in the perioperative period. Although the work group identified safety issues specific to surgical scenarios, it believed that with the use of standardized guidelines and a checklist, continuation of insulin pump therapy during the perioperative period is feasible. A sample set of protocols have been developed and are summarized. A policy outlining clear procedures should be established at the institutional level to guide physicians and other staf if the devices are to be employed during the perioperative period. Additional clinical experience with the technology in surgical scenarios is needed, and consensus should be developed for insulin pump use in the perioperative phases of care.",
keywords = "Diabetes mellitus, Insulin pump, Perioperative care",
author = "Boyle, {Mary E.} and Seifert, {Karen M.} and Beer, {Karen A.} and Apsey, {Heidi A.} and Nassar, {Adrienne A.} and Littman, {Stephanie D.} and Magallanez, {Janice M.} and Schlinkert, {Richard T.} and Stearns, {Joshua D.} and Hovan, {Michael J.} and Cook, {Curtiss B.}",
year = "2012",
doi = "10.1177/193229681200600123",
language = "English (US)",
volume = "6",
pages = "184--190",
journal = "Journal of diabetes science and technology",
issn = "1932-2968",
publisher = "Diabetes Technology Society",
number = "1",

}

TY - JOUR

T1 - Guidelines for application of continuous subcutaneous insulin infusion (insulin pump) therapy in the perioperative period

AU - Boyle, Mary E.

AU - Seifert, Karen M.

AU - Beer, Karen A.

AU - Apsey, Heidi A.

AU - Nassar, Adrienne A.

AU - Littman, Stephanie D.

AU - Magallanez, Janice M.

AU - Schlinkert, Richard T.

AU - Stearns, Joshua D.

AU - Hovan, Michael J.

AU - Cook, Curtiss B.

PY - 2012

Y1 - 2012

N2 - Case reports indicate that diabetes patients receiving outpatient insulin pump therapy have been allowed to continue treatment during surgical procedures. Although allowed during surgery, there is actually little information in the medical literature on how to manage patients receiving insulin pump therapy during a planned surgical procedure. A multidisciplinary work group reviewed current information regarding the use of insulin pumps in the perioperative period. Although the work group identified safety issues specific to surgical scenarios, it believed that with the use of standardized guidelines and a checklist, continuation of insulin pump therapy during the perioperative period is feasible. A sample set of protocols have been developed and are summarized. A policy outlining clear procedures should be established at the institutional level to guide physicians and other staf if the devices are to be employed during the perioperative period. Additional clinical experience with the technology in surgical scenarios is needed, and consensus should be developed for insulin pump use in the perioperative phases of care.

AB - Case reports indicate that diabetes patients receiving outpatient insulin pump therapy have been allowed to continue treatment during surgical procedures. Although allowed during surgery, there is actually little information in the medical literature on how to manage patients receiving insulin pump therapy during a planned surgical procedure. A multidisciplinary work group reviewed current information regarding the use of insulin pumps in the perioperative period. Although the work group identified safety issues specific to surgical scenarios, it believed that with the use of standardized guidelines and a checklist, continuation of insulin pump therapy during the perioperative period is feasible. A sample set of protocols have been developed and are summarized. A policy outlining clear procedures should be established at the institutional level to guide physicians and other staf if the devices are to be employed during the perioperative period. Additional clinical experience with the technology in surgical scenarios is needed, and consensus should be developed for insulin pump use in the perioperative phases of care.

KW - Diabetes mellitus

KW - Insulin pump

KW - Perioperative care

UR - http://www.scopus.com/inward/record.url?scp=84863602559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863602559&partnerID=8YFLogxK

U2 - 10.1177/193229681200600123

DO - 10.1177/193229681200600123

M3 - Article

VL - 6

SP - 184

EP - 190

JO - Journal of diabetes science and technology

JF - Journal of diabetes science and technology

SN - 1932-2968

IS - 1

ER -